Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4761465
Max Phase: Preclinical
Molecular Formula: C16H12N4O3
Molecular Weight: 308.30
Molecule Type: Unknown
Associated Items:
ID: ALA4761465
Max Phase: Preclinical
Molecular Formula: C16H12N4O3
Molecular Weight: 308.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Nc1cccc([N+](=O)[O-])c1)Nc1ccc2cccnc2c1
Standard InChI: InChI=1S/C16H12N4O3/c21-16(18-12-4-1-5-14(9-12)20(22)23)19-13-7-6-11-3-2-8-17-15(11)10-13/h1-10H,(H2,18,19,21)
Standard InChI Key: YGGGFAQVXHMPDF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 308.30 | Molecular Weight (Monoisotopic): 308.0909 | AlogP: 3.79 | #Rotatable Bonds: 3 |
Polar Surface Area: 97.16 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.06 | CX Basic pKa: 4.04 | CX LogP: 3.22 | CX LogD: 3.22 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.57 | Np Likeness Score: -1.80 |
1. Yang Z,Zhou Y,Zhong L. (2021) Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation., 33 [PMID:33333161] [10.1016/j.bmcl.2020.127745] |
Source(1):